论文部分内容阅读
西安杨森制药有限公司(Xian-Janssen)是中国和比利时合资兴建与经营的现代化制药企业,于1985年10月22日正式成立,是目前中国医药工业界规模最大,药品品种最多,剂型最全的先进技术型合资企业。 西安杨森制药有限公司中方股东由四家组成,即陕西省医药工业公司陕西省汉江制红厂、中国医药工业公司和中国医药对外贸易总公司,合资方比利时杨森公司是世界著名的制药企业,它是1993年全美排名前30位的,全球领先的医药保健品跨国公司美国强生公司的成员之一。 西安杨森公司实行董事会领导下的总裁负责制,董事会由中外双方各6名人员组成,公司下设生产、市场、财务、总部、公关、人事、行政、出口、安全、购买、维修、人力资源等专业管理部门。生产厂区位于古城西安市,厂房的设计、建造、设备安装、调试、生产工艺等均达到世界卫生组织(WHO)的要求、以及药品生产管理规范(GMP)标准。自1990年以来,公司连年跨入中国500家最大工业企业和300家最大外商投资工业企业,1992年、1993年连续被国家权威机构评为中国十大最佳合资企业第一名。目前已投放中国市场的药品有普瑞博思、吗丁啉、斯皮仁诺、达克宁、里素劳、息斯敏、西比灵、易蒙停、安乐士、安度利可、采乐洗剂和立复汀等12种杨森专利产品。
Xian-Janssen Pharmaceutical Co., Ltd. (Xian-Janssen) is a modern pharmaceutical company jointly established and operated by China and Belgium. It was formally established on October 22, 1985. It is the largest pharmaceutical industry in China, with the largest variety of drugs and the most complete dosage forms. Advanced technology type joint venture. The Chinese shareholder of Xi’an Janssen Pharmaceutical Co., Ltd. is composed of four companies: Shaanxi Pharmaceutical Corporation Shaanxi Hanjiang Hongye Plant, China Pharmaceutical Industry Corporation and China National Pharmaceutical Foreign Trade Corporation. The joint venture Belgian Janssen is a world famous pharmaceutical company. It is a member of the United States Johnson & Johnson, the world’s leading multinational pharmaceutical and health products company, ranked in the top 30 in the United States in 1993. Xi’an Janssen Co., Ltd. implements the president responsibility system under the leadership of the board of directors. The board of directors is composed of 6 Chinese and foreign personnel. The company has production, marketing, finance, headquarters, public relations, personnel, administration, export, security, purchasing, maintenance, human resources, etc. Professional management department. The production plant is located in the ancient city of Xi’an. The design, construction, equipment installation, commissioning, and production processes of the plant meet the requirements of the World Health Organization (WHO) and the GMP standards. Since 1990, the company has entered China’s 500 largest industrial companies and 300 of the largest foreign-invested industrial enterprises in successive years. In 1992 and 1993, it was continuously ranked as the top ten best joint ventures in China by state authorities. Drugs that have been placed on the Chinese market include prebostin, domperidone, Sporano, Dakenin, Rissourus, Alxmin, Sibelin, Yimeng, Ambrose, Andorico, and Celebrex There are 12 kinds of Janssen patent products such as agent and lithopone.